ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Polivy Chemoimmunotherapy Regimen Approved to Treat DLBCL
June 12, 2019Polivy Chemoimmunotherapy Regimen Approved to Treat DLBCL. -
Vertex's VX-445 triple combination regimen achieves main goals of two late-stage studies in CF
March 07, 2019Vertex Pharmaceuticals on Wednesday announced that a three-drug regimen combining the investigational next-generation corrector VX-445 with Kalydeco (ivacaftor) and tezacaftor met the primary endpoints of two Phase III studies in patients with cystic fibr
Pharma Sources Insight January 2025
